Thus, APL patients with the FLT3-D835 mutation also showed a worse prognosis compared to APL patients with wild-type FLT3. However, the number of studies including information on the FLT3-D835 status is relatively small. This evidence concerns the gene FLT3 and acute promyelocytic leukemia.